Methicillin-Resistant Staphylococcus Aureus (MRSA): Difference between revisions

No edit summary
 
(25 intermediate revisions by 5 users not shown)
Line 1: Line 1:
==Background==
{{MRSA background}}
Suspect MRSA infection/carrier in patients who present with:
#multiple skin sites
#recurrent infection
#pt who has been in close contact of person with Hx of MRSA
#infection showing early necrosis
#two kinds: hospital acquired and community acquired


==Prevention==
==Management==
# good hand hygiene
*Treatment/resistance is different for each type; check specific page
# avoid sharing personal items with carriers
# wash common household items with bleach and hot water
# wash soiled sheets, towels, clothes in hot water with bleach and dry in hot dryer
# Eradicate carriers:
# mupirocin 2%: apply to each nostril TID x 5days
# Hibiclens wash daily x 5 days
# consider oral antibiotics 


==Treatment==
==List of MRSA Antibiotics==
# Antibiotics
{{#ask:[[Has MRSA::S]] |format=ul }}
## Keflex + Bactrim DS
## clindamycin
## doxycycline
## Vancomycin IV if severe infection/sepsis
# I&D if abscess
##(antibiotics not needed if no e/o cellulitis)


==Source==
==Table Overview==
Adapted from Donaldson
{{Clinically Relevant Bacteria}}


==See Also==
*[[Microbiology (Main)]]
*[[Staph. aureus]]
==References==
==References==
<references/>
[[Category:ID]]
[[Category:ID]]

Latest revision as of 13:15, 30 August 2025

Background

Risk Factors

  • Multiple skin sites
  • Recurrent infection
  • Close contact of person with Hx of MRSA
  • Infection showing early necrosis

Management

  • Treatment/resistance is different for each type; check specific page

List of MRSA Antibiotics

Table Overview

See Also

References

References